According to the latest report by IMARC Group, titled “Nuclear Medicine Equipment Market Report by Product (Single-Photon Emission Computed Tomography, Positron Emission Tomography, Planar Scintigraphy), Application (Neurology, Oncology, Cardiology, and Others), End User (Hospitals, Imaging Centers, Academic and Research Institutes, and Others), and Region 2025-2033,” the global nuclear medicine equipment market reached a value of USD 3.3 Billion in 2024. Nuclear medicine is a branch of radiology that is used for visualizing the function and structure of a tissue, bone, system or organ. It includes various therapies, such as radioactive iodine, antibodies, phosphorus and other materials therapy. Nuclear medicine therapies are performed by introducing radionuclides or radiopharmaceuticals into the body. The behavior of the radionuclide is measured through a gamma camera, generator, nuclear reactor, and cyclotron. Nuclear medicine is used for diagnosing various conditions, which include brain tumors, and prostate, breast, lung, and head and neck cancers. Besides this, it also helps to detect organ enlargement, hematomas, cysts, infections, arthritis, and fractures.
Global Nuclear Medicine Equipment Market Trends:
The rising prevalence of heart-based diseases, neurological disorders, and cancers has led to an increase in the awareness regarding the importance of early diagnosis, which is primarily driving the market growth. The rising awareness is further leading to the widespread establishment of diagnostic centers, which is fueling the demand for these systems. Other than this, various technological advancements are contributing to the growth of the market. For instance, leading players have been developing modern software that helps to improve the acquisition, and image detail and sharpness of gamma and positron emission tomography (PET) cameras. Moreover, significant improvements in the healthcare infrastructure, and a rapid shift toward high-resolution imaging solutions are some of the other factors that are creating a positive outlook for the market. Looking forward, the market is projected to reach USD 5.4 Billion by 2033, expanding at a CAGR of 5.56% during the forecast period (2025-2033).
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Product, Application, End User, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Biodex Medical Systems Inc. (Mirion Technologies Inc.), Cardinal Health Inc., CMR Naviscan Corporation, DDD-Diagnostic A/S, Digirad Corporation, General Electric Company, Koninklijke Philips N.V., Mediso Ltd., Neusoft Corporation, Siemens AG, SurgicEye GmbH and Toshiba Corporation |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas: - +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800